Blue Sail Medical Co.,Ltd. (SHE:002382)
China flag China · Delayed Price · Currency is CNY
5.91
+0.02 (0.34%)
Sep 14, 2026, 3:04 PM CST

Blue Sail Medical Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
6,5745,6626,1774,8504,8348,064
Other Revenue
40.7477.4776.3776.7366.1844.59
6,6145,7406,2534,9274,9008,109
Revenue Growth
8.82%-8.21%26.91%0.54%-39.56%3.04%
Cost of Revenue
5,0594,9315,2624,3934,4814,382
Gross Profit
1,555808.29991.03533.82419.173,726
Selling, General & Admin
862.63814.78814.49788.43701.86765.15
Research & Development
260.8254.42341.92290.75352.49438.52
Other Operating Expenses
45.0243.2933.1827.5636.9254.78
Operating Expenses
1,2091,1201,2121,1251,0931,279
Operating Income
346.52-312.09-221.29-591.62-674.022,448
Interest Expense
-344.72-303.47-278.98-180.47-129.48-133.32
Interest & Investment Income
21.5641.5230.3840.67294.4481.06
Currency Exchange Gain (Loss)
-25.1830.0453.0933.8862.8-86.36
Other Non Operating Income (Expenses)
-5.5-17.33-5.72-6.69-12.26-27.4
EBT Excluding Unusual Items
-7.31-561.33-422.51-704.23-458.512,282
Impairment of Goodwill
------1,698
Gain (Loss) on Sale of Investments
-6.90.5-11.170.63-6.741,098
Gain (Loss) on Sale of Assets
-0.03-1.65-0.84-1.920.07-1.89
Asset Writedown
-169.42-157.91-6.29-21.47-6.94-370.68
Legal Settlements
17.2317.23----
Other Unusual Items
13.8942.0239.1434.3866.2638.08
Pretax Income
-152.55-661.14-401.6-622.61-405.861,347
Income Tax Expense
305.77137.2863.32-54.25-33.54191.65
Earnings From Continuing Operations
-458.32-798.41-464.92-568.36-372.321,156
Minority Interest in Earnings
-76.4439.4719.31-00
Net Income
-534.75-758.94-445.61-568.36-372.321,156
Net Income to Common
-534.75-758.94-445.61-568.36-372.321,156
Net Income Growth
------34.28%
Shares Outstanding (Basic)
9399991,0131,0151,0061,023
Shares Outstanding (Diluted)
9399991,0131,0151,0061,051
Shares Change
-10.57%-1.40%-0.21%0.86%-4.22%3.36%
EPS (Basic)
-0.57-0.76-0.44-0.56-0.371.13
EPS (Diluted)
-0.57-0.76-0.44-0.56-0.371.10
EPS Growth
------36.42%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
170.92-95.29-638.43-847.03-402.39-336.22
Free Cash Flow Per Share
0.18-0.10-0.63-0.83-0.40-0.32
Dividend Per Share
----0.400-
Dividend Growth
----0%-
Gross Margin
23.52%14.08%15.85%10.83%8.55%45.96%
Operating Margin
5.24%-5.44%-3.54%-12.01%-13.75%30.19%
Profit Margin
-8.09%-13.22%-7.13%-11.54%-7.60%14.25%
Free Cash Flow Margin
2.58%-1.66%-10.21%-17.19%-8.21%-4.15%
EBITDA
902.23243.3289.58-84.34-200.952,765
EBITDA Margin
13.64%4.24%4.63%-1.71%-4.10%34.10%
D&A For EBITDA
555.71555.39510.87507.27473.06317.51
EBIT
346.52-312.09-221.29-591.62-674.022,448
EBIT Margin
5.24%-5.44%-3.54%-12.01%-13.75%30.19%
Effective Tax Rate
-----14.22%
Revenue as Reported
6,6145,7406,2534,9274,9008,109
Advertising Expenses
-84.6480.2988.3254.6124.98